Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

Cited by (1,019)

Items 401–500 of 1,019

1. Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
   C. Roger White, David W. Garber, Gattadahalli M. Anantharamaiah · 2014 · Journal of Lipid Research
2. Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis
   Gantsetseg Tumurkhuu, Jargalsaikhan Dagvadorj, Rebecca A. Porritt, Timothy R. Crother, Kenichi Shimada, Elizabeth J. Tarling, Ebru Erbay, Moshe Arditi, Shuang Chen · 2018 · Cell Metabolism
3. PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016
   Banach, Maciej, Jankowski, Piotr, Jóźwiak, Jacek, Cybulska, Barbara, Windak, Adam, Guzik, Tomasz, Mamcarz, Artur, Broncel, Marlena, Tomasik, Tomasz · 2017 · Archives of Medical Science
4. Generating comparative evidence on new drugs and devices after approval
   Andrea Cipriani, John P. A. Ioannidis, Peter Malcolm Rothwell, Paul Glasziou, Tianjing Li, Adrian F. Hernandez, Anneka Tomlinson, Robert John Simes, Huseyin Naci · 2020 · The Lancet
5. HDL and type 2 diabetes: the chicken or the egg?
   Eva Xepapadaki, Ioanna Nikdima, Eleftheria C. Sagiadinou, Evangelia Zvintzou, Kyriakos E. Kypreos · 2021 · Diabetologia
6. Is a High HDL-Cholesterol Level Always Beneficial?
   Beata Franczyk, Jacek Rysz, Janusz Ławiński, Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka · 2021 · Biomedicines
7. Metabolic Syndrome, ESRD, and Death in CKD
   Sankar Dass Navaneethan, Jesse D. Schold, John P. Kirwan, Susana Arrigain, Stacey E. Jolly, Emilio D. Poggio, Srinivasan Beddhu, Joseph V. Nally · 2013 · Clinical Journal of the American Society of Nephrology
8. High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity
   Anand K. Rohatgi · 2015 · Progress in Cardiovascular Diseases
9. Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation
   Stefan Offermanns, Markus Schwaninger · 2015 · Trends in Molecular Medicine
10. The Relationships Between Cardiovascular Disease and Diabetes
    Jason Ciril Kovacic, Jose Maria Castellano, Michael E. Farkouh, Valentı́n Fuster · 2014 · Endocrinology and Metabolism Clinics of North America
11. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus
    Hyung Joon Joo, Sang-A Cho, Soon Jun Hong, Seung‐Ho Hur, Jang‐Ho Bae, Dong‐Ju Choi, Youngkeun Ahn, Jong‐Seon Park, Rak Kyeong Choi, Donghoon Choi et al. · 2016 · Lipids in Health and Disease
12. Dyslipidemia Management in Adults With Diabetes
    Julieta Lazarte, Robert Alexander Hegele · 2019 · Canadian Journal of Diabetes
13. Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
    Andreja Rehberger Likozar, Mark Zavrtanik, Miran Šebeštjen · 2020 · Annals of Medicine
14. Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study
    Aurélie Lenglet, Sophie Liabeuf, N. El Esper, Sandrine Brisset, Janette Mansour, Anne‐Sophie Lemaire‐Hurtel, Aurélien Mary, Michel Brazier, Saı̈d Kamel, Romuald Mentaverri et al. · 2016 · Nephrology Dialysis Transplantation
15. PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
    Yehuda Handelsman, Norman E. Lepor · 2018 · Journal of the American Heart Association
16. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence
    Maki, Kevin C., Bays, Harold E., Dicklin, Mary R. · 2012 · Journal of Clinical Lipidology
17. Statin-associated muscle symptoms—Managing the highly intolerant
    James M. Backes, Janelle F. Ruisinger, Cheryl Gibson, Patrick M. Moriarty · 2017 · Journal of clinical lipidology
18. Clinical approach to the inflammatory etiology of cardiovascular diseases
    Massimiliano Ruscica, Alberto Corsini, Nicola Ferri, Maciej Banach, Cesare Riccardo Sirtori · 2020 · Pharmacological Research
19. Existing and emerging strategies to lower Lipoprotein(a)
    Gregory G. Schwartz, Christie Mitchell Ballantyne · 2022 · Atherosclerosis
20. The Treatment of Disorders of Lipid Metabolism
    Klaus Georg Parhofer · 2016 · Deutsches Ärzteblatt international
21. Dyslipidemia and Cardiovascular Disease in Women
    Renata Cífková, Alena Krajčoviechová · 2015 · Current Cardiology Reports
22. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
    Chengfeng Qiu, Xiang Zhao, Quan Zhou, Zhen Zhang · 2017 · Lipids in Health and Disease
23. Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
    Richard Preston Mason, Hazem Dawoud, Robert Francis Jacob, Samuel C. R. Sherratt, Tadeusz Maliñski · 2018 · Biomedicine & Pharmacotherapy
24. Highlighting Residual Atherosclerotic Cardiovascular Disease Risk
    Yunosuke Matsuura, Jenny E. Kanter, Karin Bornfeldt · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
25. The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism
    Anouar Hafiane, Karina Gasbarrino, Stella Styliani Daskalopoulou · 2019 · Metabolism
26. Atherosclerosis
    Mohammed Shamim Rahman, Kevin J. Woollard · 2017 · Advances in experimental medicine and biology
27. Atherosclerosis in Systemic Lupus Erythematosus
    George Stojan, Michelle Petri · 2013 · Journal of Cardiovascular Pharmacology
28. HDL and cholesterol: life after the divorce?
    Kasey C. Vickers, Alan Thomas Remaley · 2013 · Journal of Lipid Research
29. Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials
    Christina Goldie, Allen J. Taylor, Peter Nguyen, Cody W. McCoy, Xue-Qiao Zhao, David Preiss · 2015 · Heart
30. Effects of dyslipidaemia on monocyte production and function in cardiovascular disease
    Mohammed Shamim Rahman, Andrew James Murphy, Kevin J. Woollard · 2017 · Nature Reviews Cardiology
31. Dyslipidemia and its therapeutic challenges in renal transplantation
    Riella, L.V., Gabardi, S., Chandraker, A. · 2012 · American Journal of Transplantation
32. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis
    Haitham M. Ahmed, Michael J. Miller, Khurram Nasir, John William McEvoy, David M. Herrington, Roger Scott Blumenthal, Michael Joseph Blaha · 2016 · American Journal of Epidemiology
33. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes
    Connie Ng Hess, Cecilia C. Low Wang, William R. Hiatt · 2017 · Annual Review of Medicine
34. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity
    Kavisha Singh, Alvin Chandra, Thomas Sperry, Parag H. Joshi, Amit Khera, Salim S. Virani, Christie Mitchell Ballantyne, James D. Otvos, Robin P. F. Dullaart, Eke G. Gruppen et al. · 2020 · Circulation
35. New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
    Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi · 2022 · Diabetes & Metabolism Journal
36. Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression
    Navjot Kaur, Avaneesh Kumar Pandey, Harish Negi, Nusrat Shafiq, Srinivas Reddy, Harpreet Kaur, Neelima Chadha, Samir Malhotra · 2014 · PLoS ONE
37. Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
    Claudia Daniela Fuchs, Thierry Claudel, Michael Trauner · 2014 · Trends in Endocrinology and Metabolism
38. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment
    Karl Martin Wissing, Lissa Pipeleers · 2014 · Transplantation Reviews
39. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials
    Amirhossein Sahebkar, Guglielmo Beccuti, Luis E. Simental‐Mendía, Valério Nobili, Simona Bo · 2016 · Pharmacological Research
40. Triglycerides and cardiovascular disease
    Oluwayemisi Esan, Anthony S. Wierzbicki · 2021 · Current Opinion in Cardiology
41. Consensus statement on management of dyslipidemia in Indian subjects
    K. Sarat Chandra, Manish Bansal, Tiny Nair, Shamanna Seshadri Iyengar, Rajeev Gupta, Subhash Chand Manchanda, Padinhare Purayil Mohanan, V. Dayasagar Rao, C.N. Manjunath, J.P.S. Sawhney et al. · 2014 · Indian Heart Journal
42. Mendelian randomization studies
    Brian A. Ference · 2015 · Current Opinion in Lipidology
43. The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes
    Stahel, Priska, Xiao, Changting, Hegele, Robert A., Lewis, Gary F. · 2018 · Canadian Journal of Cardiology
44. Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial
    Todd J. Anderson, William E. Boden, Patrice M. Desvigne-Nickens, Jerome L. Fleg, Moti L. Kashyap, Ruth McBride, Jeffrey L. Probstfield · 2014 · New England Journal of Medicine
45. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
    Leo E. Akioyamen, Jacques J. Genest, Anna Chu, Happy Inibhunu, Dennis T. Ko, Jack V. Tu · 2018 · Journal of clinical lipidology
46. Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management
    Osman Najam, Kausik Kumar Ray · 2015 · Cardiology and Therapy
47. A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease
    David G. Kallend, Joannes A. A. Reijers, Suleyman Eralp Bellibas, Alain Bobillier, H.J.M. Kempen, Johanna Louise I. Burggraaf, Matthijs Moerland, P. Wijngaard · 2015 · European Heart Journal - Cardiovascular Pharmacotherapy
48. Update on marine omega-3 fatty acids: Management of dyslipidemia and current omega-3 treatment options
    HOWARD S. WEINTRAUB · 2013 · Atherosclerosis
49. HDL, Atherosclerosis, and Emerging Therapies
    Anouar Hafiane, Jacques J. Genest · 2013 · Cholesterol
50. Moderate to High Concentrations of High-Density Lipoprotein From Healthy Subjects Paradoxically Impair Human Endothelial Progenitor Cells and Related Angiogenesis by Activating Rho-Associated Kinase Pathways
    Chun‐Yao Huang, Feng‐Yen Lin, Chun‐Ming Shih, Heng‐Kien Au, Yu‐Jia Chang, Hironori Nakagami, Ryuichi Morishita, Nen‐Chung Chang, Kou‐Gi Shyu, Jaw‐Wen Chen · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
51. Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol Are Associated With Monocytosis and Atherosclerosis
    Anjali Ganda, Martin Magnusson, Laurent Yvan‐Charvet, Bo Hedblad, Gunnar Engström, Ding Ai, Thomas J. Wang, Robert Edgardo Gerszten, Olle Melander, Alan R. Tall · 2013 · Circulation
52. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome
    Sundararajan Srikanth, PRAKASH C. DEEDWANIA · 2016 · Current Hypertension Reports
53. High lipoprotein(a): Actionable strategies for risk assessment and mitigation
    Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, Wess Boatwright, Christie Mitchell Ballantyne · 2024 · American Journal of Preventive Cardiology
54. Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein
    Mingxia Liu, Jeongmin Seo, Jeremy C. Allegood, Xin Bi, Xuewei Zhu, Elena Y. Boudyguina, Abraham K. Gebre, Dorit Avni, Dharika Shah, Mary G. Sorci‐Thomas et al. · 2013 · Journal of Biological Chemistry
55. Saroglitazar for the treatment of dyslipidemia in diabetic patients
    Shashank Joshi · 2015 · Expert Opinion on Pharmacotherapy
56. HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
    R. Kannan Mutharasan, Colby Shad Thaxton, Jarett D. Berry, Martha L. Daviglus, Chun Yuan, Jie Sun, Colby R. Ayers, Donald M. Lloyd‐Jones, John T. Wilkins · 2017 · Journal of Lipid Research
57. The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
    Nathan K. P. Wong, Stephen James Nicholls, Joanne T. M. Tan, Christina A. Bursill · 2018 · International Journal of Molecular Sciences
58. A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels
    Kirstin A. Carswell, Ajay P. Belgaumkar, Stephanie A. Amiel, Ameet G. Patel · 2015 · Obesity Surgery
59. High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
    Sony Tuteja, Daniel James Rader · 2014 · Clinical Pharmacology & Therapeutics
60. Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting
    Emiliano Angeloni, Francesco Paneni, Ulf Landmesser, Umberto Benedetto, Giovanni Melina, Thomas Felix Lüscher, Massimo Volpe, R. Sinatra, Francesco Cosentino · 2013 · European Heart Journal
61. Recomendaciones preventivas cardiovasculares
    Á. M. Martín Galán, Carlos Brotons Cuixart, Fernando Villar Álvarez, Jorge Navarro Pérez, José María Lobos-Bejarano, Ricardo Ortega Sánchez-Pinilla, Enrique Martín Rioboó, José Ramón Banegas Banegas, Domingo Orozco‐Beltrán, Vicente Francisco Gil-Guillén · 2012 · Atención Primaria
62. Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism
    Richard Preston Mason, Robert Francis Jacob · 2014 · Biochimica et Biophysica Acta (BBA) - Biomembranes
63. HDL-cholesterol and cardiovascular disease: rethinking our approach
    Siddiqi, Hasan K., Kiss, Daniel, Rader, Daniel · 2015 · Current Opinion in Cardiology
64. When should we measure lipoprotein (a)?
    Karam Kostner, Winfried März, Gerhard Max Kostner · 2013 · European Heart Journal
65. Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
    Liyao Fu, Shi Tai, Jiaxing Sun, Ningjie Zhang, Ying Zhou, Zhenhua Xing, Yongjun Wang, Shenghua Zhou · 2022 · Diabetes Care
66. HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients
    Wijtske Annema, Arne Dikkers, Jan Freark de Boer, Robin P. F. Dullaart, Jan‐Stephan Sanders, Stephan J. L. Bakker, Uwe J.F. Tietge · 2015 · Journal of the American Society of Nephrology
67. GPR109A and Vascular Inflammation
    Joshua T. Chai, Janet E. Digby, Robin P. Choudhury · 2013 · Current Atherosclerosis Reports
68. MicroRNA expression signature in human abdominal aortic aneurysms
    Matthew C. Pahl, Kimberly Derr, Gábor Gäbel, Irene Hinterseher, James R. Elmore, Charles M. Schworer, Thomas C. Peeler, David P. Franklin, John L Gray, David J. Carey et al. · 2012 · BMC Medical Genomics
69. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort
    Robert W. McGarrah, Damian M. Craig, Carol S. Haynes, Z. Elaine Dowdy, Svati Hasmukh Shah, William E. Kraus · 2016 · Atherosclerosis
70. Pharmacological Intervention to Modulate HDL: What Do We Target?
    Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard William James, Miguel A. Frias · 2018 · Frontiers in Pharmacology
71. Beyond Coronary Calcification, Family History, and C-Reactive Protein
    Purav S. Mody, Parag H. Joshi, Amit Khera, Colby R. Ayers, Anand K. Rohatgi · 2016 · Journal of the American College of Cardiology
72. Cholesterol efflux capacity: An introduction for clinicians
    Malcolm O. Anastasius, Maaike Kockx, Wendy Jessup, DAVID R. SULLIVAN, Kerry‐Anne Rye, Leonard Kritharides · 2016 · American Heart Journal
73. Cholesterol levels and long-term rates of community-acquired sepsis
    Faheem W. Guirgis, John P. Donnelly, Sunita Dodani, George Howard, Monika M. Safford, Emily B. Levitan, Henry E. Wang · 2016 · Critical Care
74. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis
    Taufiq Salahuddin, Balaji Natarajan, Martin Peter Playford, Aditya A. Joshi, Heather Teague, Youssef Masmoudi, Mariana Selwaness, Marcus Y. Chen, David A. Bluemke, Nehal N. Mehta · 2015 · European Heart Journal
75. Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study
    Langsted, Anne, Nordestgaard, Børge G, Kamstrup, Pia R · 2021 · European Heart Journal
76. The Addition of Niacin to Statin Therapy Improves High-Density Lipoprotein Cholesterol Levels But Not Metrics of Functionality
    Amit V. Khera, Parin J. Patel, Muredach P. Reilly, Daniel James Rader · 2013 · Journal of the American College of Cardiology
77. Niacin: an old lipid drug in a new NAD+ dress
    Mario Romani, Dina Hofer, Elena Katsyuba, Johan H. Auwerx · 2019 · Journal of Lipid Research
78. Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients
    Patricia Delfin Maningat, Jan L. Breslow · 2011 · New England Journal of Medicine
79. Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans
    Carlos Olimpo Mendivil, Jeremy D. Furtado, Allyson M. Morton, Liyun Wang, Frank M. Sacks · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
80. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles
    Yi He, Graziella E. Ronsein, Chongren Tang, Gail Pairitz Jarvik, William Sean Davidson, Vishal M Kothari, Hyun Deok Song, Jere P. Segrest, Karin Bornfeldt, Jay W. Heinecke · 2020 · Circulation Research
81. Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
    Baihui Zhang, Fan Yin, Ya-Nan Qiao, Shoudong Guo · 2022 · Frontiers in Molecular Biosciences
82. American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
    Shailendra B. Patel, Kathleen Louise Wyne, Samina Afreen, Ligia Maria Belalcazar, Melanie D. Bird, Sarah Coles, Joel C. Marrs, Carol Chiung‐Hui Peng, Vishnu Priya Pulipati, Shahnaz Sultan et al. · 2025 · Endocrine Practice
83. Association Between Serum High‐Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW‐CKD
    K. Nam, T. Chang, Y. S. Joo, Joohwan Kim, Sang-Mi Lee, Changhyun Lee, H. Yun, J. Park, T. Yoo, Su-Ah Sung et al. · 2019 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
84. Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies
    Scott M. Gordon, Jingyuan Deng, Alex B. Tomann, AMY SANGHAVI SHAH, Long Jason Lu, William Sean Davidson · 2013 · Molecular & Cellular Proteomics
85. New Therapeutic Approaches to the Treatment of Dyslipidemia
    Daniel James Rader · 2016 · Cell Metabolism
86. Eicosapentaenoic acid inhibits oxidation of ApoB-containing lipoprotein particles of different size in vitro when administered alone or in combination with Atorvastatin active metabolite compared with other triglyceride-lowering agents
    Mason, R. Preston, Sherratt, Samuel C.R., Jacob, Robert F. · 2016 · Journal of Cardiovascular Pharmacology
87. Statin Intolerance: A Literature Review and Management Strategies
    David R. Saxon, Robert H. Eckel · 2016 · Progress in Cardiovascular Diseases
88. Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
    Brinton, Eliot A, Ballantyne, Christie M, Bays, Harold E, Kastelein, John J, Braeckman, Rene A, Soni, Paresh N · 2013 · Cardiovascular Diabetology
89. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice
    Linzhang Huang, Baoyan Fan, Ang Ma, Philip W. Shaul, Haibo Zhu · 2015 · Journal of Lipid Research
90. Assessing the Functional Properties of High-Density Lipoproteins: An Emerging Concept in Cardiovascular Research
    Michela Triolo, Wijtske Annema, Robin P. F. Dullaart, Uwe J.F. Tietge · 2013 · Biomarkers in Medicine
91. Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies
    Aditya D. Hendrani · 2016 · World Journal of Cardiology
92. The role of monocytosis and neutrophilia in atherosclerosis
    Dimitry A. Chistiakov, Andrey V. Grechko, Veronika A. Myasoedova, Alexandra А. Melnichenko, Alexander Nikolaevich Orekhov · 2018 · Journal of Cellular and Molecular Medicine
93. Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: systematic review and meta-analysis of trials
    Khan, Safi U, Khan, Muhammad U, Valavoor, Shahul, Khan, Muhammad Shahzeb, Okunrintemi, Victor, Mamas, Mamas A, Leucker, Thorsten M, Blaha, Michael J, Michos, Erin D · 2020 · European Journal of Preventive Cardiology
94. Dyslipidemia
    Mancini, G.B. John, Hegele, Robert A., Leiter, Lawrence A. · 2018 · Canadian Journal of Diabetes
95. Epigenetic Signatures and Vascular Risk in Type 2 Diabetes: A Clinical Perspective
    Paneni, Francesco, Costantino, Sarah, Volpe, Massimo, Lüscher, Thomas Felix, Cosentino, Francesco · 2013 · Atherosclerosis
96. Regression of Atherosclerosis: Insights from Animal and Clinical Studies
    Jonathan E. Feig · 2014 · Annals of Global Health
97. High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis
    Scott M. Gordon, Alan Thomas Remaley · 2016 · Atherosclerosis
98. Effectiveness of Combination Therapy With Statin and Another Lipid-Modifying Agent Compared With Intensified Statin Monotherapy
    Kimberly Anne Gudzune, Anne Kress Monroe, Ritu Sharma, Padmini D Ranasinghe, Yohalakshmi Chelladurai, Karen A. Robinson · 2014 · Annals of Internal Medicine
99. Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein
    Eric J. Niesor, Gregory G. Schwartz, Anne Perez, Andrea Stauffer, Alexandre Durrwell, Gabriela Suchánková, Renée Benghozi, Markus Abt, David G. Kallend · 2015 · Cardiovascular Drugs and Therapy
100. Serum lipid concentrations among persons with spinal cord injury – A systematic review and meta-analysis of the literature
     Olivia N. Gilbert, James R. Croffoot, Allen J. Taylor, Mark S. Nash, Katherine G. Schomer, Suzanne L. Groah · 2013 · Atherosclerosis